CoChat

Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes

Cashman, John R., Ryan, Daniel, McKeithan, Wesley L., Okolotowicz, Karl, Gomez-Galeno, Jorge, Johnson, Mark, Sampson, Kevin J., Kass, Robert S., Pezhouman, Arash, Karagueuzian, Hrayr S., Mercola, Mark · 2021 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Ventricular cardiac arrhythmia (VA) arises in acquired or congenital heart disease. Long QT syndrome type-3 (LQT3) is a congenital form of VA caused by cardiac sodium channel (I NaL ) SCN5A mutations that prolongs cardiac action potential (AP) and enhances I NaL current. Mexiletine inhibits I NaL and shortens the QT interval in LQT3 patients. Above therapeutic doses, mexiletine prolongs the cardiac AP. We explored structure–activity relationships (SAR) for AP shortening and prolongation using dynamic medicinal chemistry and AP kinetics in human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Using patient-derived LQT3 and healthy hiPSC-CMs, we resolved distinct SAR for AP shortening and prolongation effects in mexiletine analogues and synthesized new analogues with enhanced potency and selectivity for I NaL . This resulted in compounds with decreased AP prolongation effects, increased metabolic stability, increased I NaL selectivity, and decreased avidity for the potassium channel. This study highlights using hiPSC-CMs to guide medicinal chemistry and “drug development in a dish”.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.0c01545

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Singh S., 2020, Mexiletine
  2. Rudel R., 1994, Myology
  3. De Luca A., 2000, Mol. Pharmacol., 57, 268
  4. Alexander G. J., 1986, Neurobehav. Toxicol. Teratol., 8, 231

Cited by

See all 14

Metadata

Authors
Cashman, J. R., Ryan, D., McKeithan, W. L., Okolotowicz, K., Gomez-Galeno, J., Johnson, M., Sampson, K. J., Kass, R. S., Pezhouman, A., Karagueuzian, H. S., & Mercola, M.
Affiliations
  • Human BioMolecular Research Institute (US)
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • Human BioMolecular Research Institute, San Diego, California 92121, United States
  • Columbia University (US)
  • University of California, Los Angeles (US)
Corresponding author
Cashman, John R.
Venue
Journal of Medicinal Chemistry
Published
2021-05-04
Volume
64
Issue
9
Pages
5384-5403
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3159519281
Cited by
11
References
32
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2022: 4 · 2021: 2
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
California Institute for Regenerative Medicine (TR4-06857)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
long QT syndrome type 3, mexiletine, sodium channel blockade, SCN5A mutation, ventricular arrhythmias, iPSC-derived cardiomyocytes, cardiac action potential, structure-activity relationship, drug repurposing, antiarrhythmic drugs
MeSH terms
Cardiac Conduction System Disease, Action Potentials, Animals, Anti-Arrhythmia Agents, Behavior, Animal, Cells, Cultured, Drug Stability, Half-Life, Humans, Long QT Syndrome, Male, Mexiletine, Mice, Inbred BALB C, Structure-Activity Relationship, Drug Design, Rats, Sprague-Dawley, Myocytes, Cardiac, Mice, Rats, Induced Pluripotent Stem Cells, NAV1.5 Voltage-Gated Sodium Channel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.